Candriam SCA’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-135,316	Closed	-$417K	–	732
2023 Q1	$417K	Sell	135,316 -58,640	-30%	-$181K	﹤0.01%	813
2022 Q4	$933K	Buy	193,956 +64,627	+50%	+$311K	0.01%	710
2022 Q3	$736K	Buy	+129,329	New	+$736K	0.01%	772